China Health Financials

CHHE Stock  USD 0.33  0.00  0.00%   
We suggest to use China Health Industries fundamental analysis to find out if markets are presently mispricing the company. Put another way you can use it to find out if China Health Industries is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We have analyze and collected data for thirty-one available fundamental indicators for China Health Industries, which can be compared to its peers. The stock experiences a normal downward fluctuation but is a risky buy. Check odds of China Health to be traded at $0.3267 in 90 days.
  
Understanding current and past China Health Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of China Health's financial statements are interrelated, with each one affecting the others. For example, an increase in China Health's assets may result in an increase in income on the income statement.
Please note, the presentation of China Health's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, China Health's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of China Health's management manipulating its earnings.

China Health Stock Summary

China Health competes with Signet International, National Beverage, Vita Coco, Coca Cola, and Coca Cola. China Health Industries Holdings, Inc., through its subsidiaries, manufactures and sells health products. The company is based in Harbin City, the Peoples Republic of China. China Health operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 45 people.
InstrumentUSA Pink Sheet View All
ExchangePINK Exchange
Business Address3199-1 Longxiang Road,
SectorPersonal Products
IndustryConsumer Staples
BenchmarkDow Jones Industrial
Websitewww.chinahealthindustries.com
Phone86 45 1881 00688
CurrencyUSD - US Dollar

China Health Key Financial Ratios

There are many critical financial ratios that China Health's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that China Health Industries reports annually and quarterly.

China Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining China Health's current stock value. Our valuation model uses many indicators to compare China Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across China Health competition to find correlations between indicators driving China Health's intrinsic value. More Info.
China Health Industries is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the China Health's earnings, one of the primary drivers of an investment's value.

China Health Industries Systematic Risk

China Health's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. China Health volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on China Health Industries correlated with the market. If Beta is less than 0 China Health generally moves in the opposite direction as compared to the market. If China Health Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one China Health Industries is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of China Health is generally in the same direction as the market. If Beta > 1 China Health moves generally in the same direction as, but more than the movement of the benchmark.

China Health November 29, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of China Health help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of China Health Industries. We use our internally-developed statistical techniques to arrive at the intrinsic value of China Health Industries based on widely used predictive technical indicators. In general, we focus on analyzing China Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build China Health's daily price indicators and compare them against related drivers.

Complementary Tools for China Pink Sheet analysis

When running China Health's price analysis, check to measure China Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China Health is operating at the current time. Most of China Health's value examination focuses on studying past and present price action to predict the probability of China Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China Health's price. Additionally, you may evaluate how the addition of China Health to your portfolios can decrease your overall portfolio volatility.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios